FDA applicant

Broadmaster Biotech Corperation

Zhonghe Dist, TW1 decision2012–20121 recall

FDA records 1 decision for Broadmaster Biotech Corperation (Zhonghe Dist, TW) in 2012: 1 510(k) clearance. All are in product code NBW (System, Test, Blood Glucose, Over The Counter). Its devices cite 1 predicate, 0 of them its own earlier devices. 1 recall is linked to its devices, 1 Class I.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Broadmaster Biotech Corperation’s devices, and how often a recall has named them.

FDA decisions per year

1in 2012

2012high 1 (2012) · low 0 (2013)2026

2026 so far, outlined.

Recalls per year

1in 2014

2012high 1 (2014) · low 0 (2012)2026

Class I Class II/III not classified

FIG. 1 — Broadmaster Biotech Corperation by year, 2012–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Broadmaster Biotech Corperation’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Broadmaster”

FDA records each applicant name separately; these may or may not be the same firm.

Broadmaster Biotech, Corp. 4

Broadmaster Biotech Corperation

Which product codes does it file in?

Whose devices does it build on?

What has FDA decided for it lately?

What has been recalled?

Other applicant names beginning “Broadmaster”